|
1
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leibovich BC, Lohse CM, Crispen PL,
Boorjian SA, Thompson RH, Blute ML and Cheville JC: Histological
subtype is an independent predictor of outcome for patients with
renal cell carcinoma. J Urol. 183:1309–1315. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tyritzis SI, Papadoukakis S, Katafigiotis
I, Adamakis I, Anastasiou I, Stravodimos KG, Alamanis C,
Mitropoulos D and Constantinides CA: Implementation and external
validation of Preoperative Aspects and Dimensions Used for an
Anatomical (PADUA) score for predicting complications in 74
consecutive partial nephrectomies. BJU Int. 109:1813–1818. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ljungberg B, Campbell SC, Choi HY, Jacqmin
D, Lee JE, Weikert S and Kiemeney LA: The epidemiology of renal
cell carcinoma. Eur Urol. 60:615–621. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cohen DD, Matin SF, Steinberg JR, Zagone R
and Wood CG: Evaluation of the intact specimen after laparoscopic
radical nephrectomy for clinically localized renal cell carcinoma
identifies a subset of patients at increased risk for recurrence. J
Urol. 173:1487–1491. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Escudier B, Albiges L and Sonpavde G:
Optimal management of metastatic renal cell carcinoma: Current
status. Drugs. 73:427–438. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Valadkhan S: The spliceosome: Caught in a
web of shifting interactions. Curr Opin Struct Biol. 17:310–315.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu S and Cheng C: Alternative RNA
splicing and cancer. Wiley interdisciplinary reviews RNA.
4:547–566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Srebrow A and Kornblihtt AR: The
connection between splicing and cancer. J Cell Sci. 119:2635–2641.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lygerou Z, Christophides G and Séraphin B:
A novel genetic screen for snRNP assembly factors in yeast
identifies a conserved protein, Sad1p, also required for pre-mRNA
splicing. Mol Cell Biol. 19:2008–2020. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Makarova OV, Makarov EM and Lührmann R:
The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP
are essential for the assembly of mature spliceosomes. EMBO J.
20:2553–2563. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clague MJ, Barsukov I, Coulson JM, Liu H,
Rigden DJ and Urbé S: Deubiquitylases from genes to organism.
Physiol Rev. 93:1289–1315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Leuken RJ, Luna-Vargas MP, Sixma TK,
Wolthuis RM and Medema RH: Usp39 is essential for mitotic spindle
checkpoint integrity and controls mRNA-levels of aurora B. Cell
Cycle. 7:2710–2719. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang H, Ji X, Liu X, Yao R, Chi J, Liu S,
Wang Y, Cao W and Zhou Q: Lentivirus-mediated inhibition of USP39
suppresses the growth of breast cancer cells in vitro. Oncol Rep.
30:2871–2877. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yuan X, Sun X, Shi X, Jiang C, Yu D, Zhang
W, Guan W, Zhou J, Wu Y, Qiu Y and Ding Y: USP39 promotes the
growth of human hepatocellular carcinoma in vitro and in vivo.
Oncol Rep. 34:823–832. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
An Y, Yang S, Guo K, Ma B and Wang Y:
Reduced USP39 expression inhibits malignant proliferation of
medullary thyroid carcinoma in vitro. World J Surg Oncol.
13:2552015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li KY, Zhang J, Jiang LC, Zhang B, Xia CP,
Xu K, Chen HY, Yang QZ, Liu SW and Zhu H: Knockdown of USP39 by
lentivirus-mediated RNA interference suppresses the growth of oral
squamous cell carcinoma. Cancer Biomark. 16:137–144. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang Y, Pan XW, Li L, Chen L, Liu X, Lu
JL, Zhu XM, Huang H, Yang QW, Ye JQ, et al: Overexpression of USP39
predicts poor prognosis and promotes tumorigenesis of prostate
cancer via promoting EGFR mRNA maturation and transcription
elongation. Oncotarget. 7:22016–22030. 2016.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Method. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Zhang JW, Zhang SS, Song JR, Sun K, Zong
C, Zhao QD, Liu WT, Li R, Wu MC and Wei LX: Autophagy inhibition
switches low-dose camptothecin-induced premature senescence to
apoptosis in human colorectal cancer cells. Biochem Pharmacol.
90:265–275. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yajima I, Kumasaka MY, Thang ND, Goto Y,
Takeda K, Yamanoshita O, Iida M, Ohgami N, Tamura H, Kawamoto Y and
Kato M: RAS/RAF/MEK/ERK and PI3K/PTEN/Akt signaling in malignant
melanoma progression and therapy. Dermatol Res Pract.
2012:3541912012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vakkalanka BK and Rini BI: Targeted
therapy in renal cell carcinoma. Curr Opin Urol. 18:481–487. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Keefe SM, Nathanson KL and Rathmell WK:
The molecular biology of renal cell carcinoma. Semin Oncol.
40:421–428. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mellado B and Gascón P: Molecular biology
of renal cell carcinoma. Clin Transl Oncol. 8:706–710. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nigg EA: Cyclin-dependent protein kinases:
Key regulators of the eukaryotic cell cycle. BioEssays. 17:471–480.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sartor H, Ehlert F, Grzeschik KH, Müller R
and Adolph S: Assignment of two human cell cycle genes, CDC25C and
CCNB1, to 5q31 and 5q12, respectively. Genomics. 13:911–912. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hwang HC and Clurman BE: Cyclin E in
normal and neoplastic cell cycles. Oncogene. 24:2776–2786. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
O'Rourke MG and Ellem KA: John Kerr and
apoptosis. Med J Aust. 173:616–617. 2000.PubMed/NCBI
|
|
30
|
Rathore S, Datta G, Kaur I, Malhotra P and
Mohmmed A: Disruption of cellular homeostasis induces organelle
stress and triggers apoptosis like cell-death pathways in malaria
parasite. Cell Death Dis. 6:e18032015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Agarwal A, Mahfouz RZ, Sharma RK, Sarkar
O, Mangrola D and Mathur PP: Potential biological role of poly
(ADP-ribose) polymerase (PARP) in male gametes. Reprod Biol
Endocrinol. 7:1432009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rao VN and Reddy ES: elk-1 proteins
interact with MAP kinases. Oncogene. 9:1855–1860. 1994.PubMed/NCBI
|
|
33
|
Freeman-Cook KD, Autry C, Borzillo G,
Gordon D, Barbacci-Tobin E, Bernardo V, Briere D, Clark T, Corbett
M, Jakubczak J, et al: Design of selective, ATP-competitive
inhibitors of Akt. J Med Chem. 53:4615–4622. 2010. View Article : Google Scholar : PubMed/NCBI
|
